These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 9247205)
1. Melatonin inhibits oxidative modification of human low-density lipoprotein. Kelly MR; Loo G J Pineal Res; 1997 May; 22(4):203-9. PubMed ID: 9247205 [TBL] [Abstract][Full Text] [Related]
2. A high concentration of melatonin inhibits in vitro LDL peroxidation but not oxidized LDL toxicity toward cultured endothelial cells. Walters-Laporte E; Furman C; Fouquet S; Martin-Nizard F; Lestavel S; Gozzo A; Lesieur D; Fruchart JC; Duriez P; Teissier E J Cardiovasc Pharmacol; 1998 Oct; 32(4):582-92. PubMed ID: 9781926 [TBL] [Abstract][Full Text] [Related]
3. Cigarette smoke extract inhibits oxidative modification of low density lipoprotein. Chen C; Loo G Atherosclerosis; 1995 Jan; 112(2):177-85. PubMed ID: 7772077 [TBL] [Abstract][Full Text] [Related]
4. Effects of ebselen and probucol on oxidative modifications of lipid and protein of low density lipoprotein induced by free radicals. Noguchi N; Gotoh N; Niki E Biochim Biophys Acta; 1994 Jul; 1213(2):176-82. PubMed ID: 8025128 [TBL] [Abstract][Full Text] [Related]
6. Grape extract inhibits lipid peroxidation of human low density lipoprotein. Lanningham-Foster L; Chen C; Chance DS; Loo G Biol Pharm Bull; 1995 Oct; 18(10):1347-51. PubMed ID: 8593434 [TBL] [Abstract][Full Text] [Related]
7. Mangostin inhibits the oxidative modification of human low density lipoprotein. Williams P; Ongsakul M; Proudfoot J; Croft K; Beilin L Free Radic Res; 1995 Aug; 23(2):175-84. PubMed ID: 7581813 [TBL] [Abstract][Full Text] [Related]
8. A critical assessment of the effects of aminoguanidine and ascorbate on the oxidative modification of LDL: evidence for interference with some assays of lipoprotein oxidation by aminoguanidine. Scaccini C; Chiesa G; Jialal I J Lipid Res; 1994 Jun; 35(6):1085-92. PubMed ID: 8077847 [TBL] [Abstract][Full Text] [Related]
9. Effects of methyl 9(or 10)-hydroxy-10(or 9)-mercaptostearate and hexadecanethioic S-acid on cupric ion- or 2,2-azo-bis(2-amidinopropane) dihydrochloride (AAPH)-induced oxidation of low density lipoprotein. Tanaka M; Takada K; Higuchi T; Nakagawa M; Murase M; Tobinaga S Biol Pharm Bull; 1996 May; 19(5):692-6. PubMed ID: 8741576 [TBL] [Abstract][Full Text] [Related]
10. Resveratrol inhibits copper ion-induced and azo compound-initiated oxidative modification of human low density lipoprotein. Zou JG; Huang YZ; Chen Q; Wei EH; Hsieh TC; Wu JM Biochem Mol Biol Int; 1999 Jun; 47(6):1089-96. PubMed ID: 10410255 [TBL] [Abstract][Full Text] [Related]
11. Effects of resveratrol on oxidative modification of human low density lipoprotein. Zou J; Huang Y; Chen Q; Wei E; Cao K; Wu JM Chin Med J (Engl); 2000 Feb; 113(2):99-102. PubMed ID: 11775553 [TBL] [Abstract][Full Text] [Related]
12. Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants. Aviram M; Rosenblat M; Billecke S; Erogul J; Sorenson R; Bisgaier CL; Newton RS; La Du B Free Radic Biol Med; 1999 Apr; 26(7-8):892-904. PubMed ID: 10232833 [TBL] [Abstract][Full Text] [Related]
13. Non-oxidative modification of native low-density lipoprotein by oxidized low-density lipoprotein. Yang M; Leake DS; Rice-Evans CA Biochem J; 1996 Jun; 316 ( Pt 2)(Pt 2):377-80. PubMed ID: 8687375 [TBL] [Abstract][Full Text] [Related]
14. The antioxidative effects of the isoflavan glabridin on endogenous constituents of LDL during its oxidation. Belinky PA; Aviram M; Fuhrman B; Rosenblat M; Vaya J Atherosclerosis; 1998 Mar; 137(1):49-61. PubMed ID: 9568736 [TBL] [Abstract][Full Text] [Related]
16. The hypolipidemic natural product Commiphora mukul and its component guggulsterone inhibit oxidative modification of LDL. Wang X; Greilberger J; Ledinski G; Kager G; Paigen B; Jürgens G Atherosclerosis; 2004 Feb; 172(2):239-46. PubMed ID: 15019533 [TBL] [Abstract][Full Text] [Related]
17. Plasma thiols inhibit hemin-dependent oxidation of human low-density lipoprotein. Lynch SM; Campione AL; Moore MK Biochim Biophys Acta; 2000 May; 1485(1):11-22. PubMed ID: 10802245 [TBL] [Abstract][Full Text] [Related]
18. Protective effects of endomorphins, endogenous opioid peptides in the brain, on human low density lipoprotein oxidation. Lin X; Xue LY; Wang R; Zhao QY; Chen Q FEBS J; 2006 Mar; 273(6):1275-84. PubMed ID: 16519691 [TBL] [Abstract][Full Text] [Related]
19. Tetradecylthioacetic acid inhibits the oxidative modification of low density lipoprotein and 8-hydroxydeoxyguanosine formation in vitro. Muna ZA; Doudin K; Songstad J; Ulvik RJ; Berge RK Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3255-62. PubMed ID: 9409320 [TBL] [Abstract][Full Text] [Related]
20. Ginkgo biloba extract (EGb 761) protects human low density lipoproteins against oxidative modification mediated by copper. Yan LJ; Droy-Lefaix MT; Packer L Biochem Biophys Res Commun; 1995 Jul; 212(2):360-6. PubMed ID: 7626049 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]